Skip to content
NBDC Human Database

No datasets in the cart.

Due to system maintenance, the application system, application review by the Data Access Committee will be unavailable during the following period.
Schedule: October 5th (Mon), 2026, 9:00 - October 7th (Wed), 2026, 15:00 (JST)
We apologize for any inconvenience this may cause and appreciate your understanding.

We are currently receiving a large number of applications for data submission, and the review process is taking longer than usual.We sincerely apologize for the delay and kindly ask for your understanding. When submitting an application, we would greatly appreciate it if you could allow sufficient time for the processing.

Following a change to our organizational structure effective April 1, 2026, this division has been renamed from the "Database Center for Life Science, Joint Support-Center for Data Science Research" to the "Database Division for Life Science (DBCLS), BioData Science Initiative (BSI), National Institute of Genetics (NIG)". Where the former name still appears in the guidelines, please read it as the new name.

Dataset ID

JGAD000851

Type of data
NGS (RNA-seq, ATAC-seq)
Access criteria
Controlled-access (Type I)
Total data volume
200 GB
File formats
  • FASTQ
Research
hum0384
Date published
2024-06-20
Date modified
2025-06-30

Analysis method

RNA-seq

Materials and participants
AML (ICD10: C92.0): 4 cases
healthy control: 2 samples
  • Health status
    Mixed
  • Subject count
    44 (Mixed)
Disease
AML (C920)
Sample description
RNAs extracted from tumor cells and normal cells
  • Tissue
    Bone marrow
  • Tumor / normal
    Mixed
Sample provider
LONZA 2M-101A, 2M-101C: Bone Marrow CD34+ cells
Experimental method
RNA-seq
Target
N/A
Reagent kit
NEBNext Ultra DNA Library Prep Kit for Illumina
SMARTer Ultra Low Input RNA Kit for Sequencing
Fragmentation
Ultrasonic fragmentation
Platform
Illumina HiSeq 1500
Illumina HiSeq 2500
Read type
Single-end
Read length
60 bp

ATAC-seq

Materials and participants
AML (ICD10: C92.0): 4 + 4 cases
MDS (ICD10: D46): 30 cases
healthy control: 6 samples
  • Health status
    Mixed
  • Subject count
    44 (Mixed)
Disease
AML (C920)
MDS (D46)
Sample description
DNAs extracted from tumor cells and normal cells
  • Tissue
    Bone marrow
  • Tumor / normal
    Mixed
Sample provider
LONZA 2M-101A, 2M-101C: Bone Marrow CD34+ cells
Experimental method
ATAC-seq
Target
N/A
Reagent kit
NEBNext Ultra DNA Library Prep Kit for Illumina
Fragmentation
Tn5 transposase
Platform
Illumina HiSeq 1500
Read type
Single-end
Read length
60 bp